Specialized Oncology CRO Theradex Oncology’s full-service CRO focus on all indications and modalities, supported by MD oncologists and regulatory experts, positions it as a trusted partner for biotech and pharma companies seeking comprehensive clinical trial management in oncology.

Experienced Market Presence With over 40 years in business, Theradex has established a strong reputation and deep expertise in conducting studies for emerging biotech and pharma companies, enhancing its appeal to clients seeking reliable trial support.

Moderate Revenue Scale Generating between 100 million and 250 million dollars in revenue, Theradex presents an attractive growth opportunity for partners aiming to access mid-sized, specialized clinical trial outsourcing services.

Technology Infrastructure Utilizing a robust tech stack including PHP, Nginx, and cloud hosting services, Theradex inherits modern digital capabilities that can accommodate scalable, efficient clinical trial data management and monitoring.

Potential for Expansion Positioned alongside large CROs like IQVIA and ICON with a focused niche in oncology, Theradex offers prospects for strategic collaborations or market expansion into oncology-specific clinical trial services.